On top of 348 known job cuts across the organization last year, Roche’s Genentech division laid off an additional 141 ...

The Philadelphia Department of Commerce awarded $450,000 in matching grants to local life sciences companies in January. The funds will match the amount companies have received from federal Small ...

Under the agreement, SanegeneBio has granted Genentech exclusive worldwide rights to develop and commercialize the undisclosed program.

Genentech's CEO told the Business Times that a massive renovation set to begin in South San Francisco is meant to reimagine ...

Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY), announced today new late-breaking data from the Phase III FENtrepid study showing the investigational Bruton’s tyrosine kinase (BTK ...

The trial showed fenebrutinib reduced disability progression risk by 12% compared to Ocrevus, the only approved PPMS ...

WASHINGTON — Plenty of pharmaceutical executives have decried Democrats’ new drug pricing law as detrimental to the industry. But few are willing to say they may be willing to delay treatments for ...

The 800-person Vacaville site that once produced blockbuster cancer drugs for Genentech is transitioning to new clients under ...

The deal provides SanegeneBio with an upfront payment of $200m.

In today’s Pharmaceutical Executive Daily, a new a is expected to evolve in 2026, the FDA rejects AstraZeneca’s application ...

Genentech is honing in on an aspect of the patient community that is too often overlooked — the role of caregivers in managing rare diseases. In a recently-released short film, Genentech tells the ...